ICAM1 and systemic mastocytosis: Thus, anti-PFD1235w IgG antibodies can inhibit PfEMP1 binding and might prevent PFD1235w-expressing IEs (or close variants thereof) from binding to ICAM-1 on endothelial cells, thus providing protection against developing SM in these children.